Sotac Pharmaceuticals consolidated net profit rises 34.26% in the June 2024 quarter
Net profit of Sotac Pharmaceuticals rose 34.26% to Rs 1.45 crore in the quarter ended June 2024 as against Rs 1.08 crore during the previous quarter ended June 2023. Sales rose 1.12% to Rs 25.25 crore in the quarter ended June 2024 as against Rs 24.97 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 25.25 | 24.97 | 1 |
OPM % | 8.75 | 9.37 | - |
PBDT | 2.05 | 2.11 | -3 |
PBT | 1.30 | 1.50 | -13 |
NP | 1.45 | 1.08 | 34 |
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account